Haixi Zhang

Huyu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

SLC1A5 and NUMA1 are potential regulators and therapeutic targets of ferroptosis in diffuse large B-cell lymphoma.

SLC1A5 and NUMA1 are potential regulators and therapeutic targets of ferroptosis in diffuse large B-cell lymphoma.

Journal: Leukemia research

Published: May 19, 2026

Dual-targeted exosome nanoplatform co-delivering doxorubicin and Fuzi Lizhong Tang bioactives for synergistic DLBCL therapy and chemotherapy-induced diarrhea management.

Dual-targeted exosome nanoplatform co-delivering doxorubicin and Fuzi Lizhong Tang bioactives for synergistic DLBCL therapy and chemotherapy-induced diarrhea management.

Journal: Colloids and surfaces. B, Biointerfaces

Published: August 28, 2025

Case report: Dysphonia associated with high-dose cytarabine therapy.

Case report: Dysphonia associated with high-dose cytarabine therapy.

Journal: Frontiers in pharmacology

Published: October 28, 2024

Pyoderma gangrenosum complicated with hematological malignancies: Two case reports.

Pyoderma gangrenosum complicated with hematological malignancies: Two case reports.

Journal: Medicine

Published: March 08, 2024

Recombinant hirudin suppresses angiogenesis of diffuse large B-cell lymphoma through regulation of the PAR-1-VEGF.

Recombinant hirudin suppresses angiogenesis of diffuse large B-cell lymphoma through regulation of the PAR-1-VEGF.

Journal: Chemical biology & drug design

Published: February 23, 2024

Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma.

Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma.

Journal: BMC biotechnology

Published: January 20, 2024

Identification of TNFRSF1A as a novel regulator of carfilzomib resistance in multiple myeloma.

Identification of TNFRSF1A as a novel regulator of carfilzomib resistance in multiple myeloma.

Journal: Oncology research

Published: April 21, 2023

Case Report: An unclassified T cell lymphoma subtype with co-expression of TCR αβ and γ chains revealed by single cell sequencing.

Case Report: An unclassified T cell lymphoma subtype with co-expression of TCR αβ and γ chains revealed by single cell sequencing.

Journal: Frontiers in immunology

Published: March 11, 2023

Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression.

Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: November 01, 2022

Anti-cancer potential of selenium-chitosan-polyethylene glycol-carvacrol nanocomposites in multiple myeloma U266 cells.

Anti-cancer potential of selenium-chitosan-polyethylene glycol-carvacrol nanocomposites in multiple myeloma U266 cells.

Journal: Journal of biochemical and molecular toxicology

Published: November 01, 2022

Anticancer and Anti-inflammatory Effect of Diosmin against Dalton Ascitic Lymphoma Induced Leukemia.

Anticancer and Anti-inflammatory Effect of Diosmin against Dalton Ascitic Lymphoma Induced Leukemia.

Journal: Journal of oleo science

Published: May 06, 2021

Daphnetin exerts an anticancer effect by attenuating the pro-inflammatory cytokines.

Daphnetin exerts an anticancer effect by attenuating the pro-inflammatory cytokines.

Journal: Journal of biochemical and molecular toxicology

Published: December 04, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026